1
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global API CDMO Services Market Research Report 2022
Published Date: December 2022
|
Report Code: QYRE-Auto-24L12550
Home | Market Reports | Health| Nursing
Global API CDMO Services Market Research Report 2022
BUY CHAPTERS

Global API CDMO Services Market Research Report 2022

Code: QYRE-Auto-24L12550
Report
December 2022
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

API CDMO Services

The global API CDMO Services market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

North American market for API CDMO Services is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for API CDMO Services is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The global market for API CDMO Services in Pharmaceutical Company is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The major global companies of API CDMO Services include EUROAPI, Cambrex, Recipharm, Thermo Fisher Scientific, CordenPharma, Samsung Biologics, Lonza, Catalent and Siegfried, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.

Considering the economic change due to COVID-19, Traditional API CDMO, which accounted for % of the global market of API CDMO Services in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.

This report aims to provide a comprehensive presentation of the global market for API CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding API CDMO Services.

The API CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global API CDMO Services market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the API CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

By Company

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

  • EUROAPI
  • Cambrex
  • Recipharm
  • Thermo Fisher Scientific
  • CordenPharma
  • Samsung Biologics
  • Lonza
  • Catalent
  • Siegfried
  • PiramalPharma Solutions
  • Boehringer-Ingelheim
  • Wuxi Apptec
  • Pharmaron Beijing
  • Asymchem Laboratories (Tianjin)
  • Porton
  • SEQENS
  • Lebsa
  • Langhua Pharma

By Type

  • Traditional API CDMO
  • Highly Potent API CDMO

By Application

  • Pharmaceutical Company
  • Research Institute

By Region

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global API CDMO Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Traditional API CDMO
1.2.3 Highly Potent API CDMO
1.3 Market by Application
1.3.1 Global API CDMO Services Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Company
1.3.3 Research Institute
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global API CDMO Services Market Perspective (2017-2028)
2.2 API CDMO Services Growth Trends by Region
2.2.1 API CDMO Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 API CDMO Services Historic Market Size by Region (2017-2022)
2.2.3 API CDMO Services Forecasted Market Size by Region (2023-2028)
2.3 API CDMO Services Market Dynamics
2.3.1 API CDMO Services Industry Trends
2.3.2 API CDMO Services Market Drivers
2.3.3 API CDMO Services Market Challenges
2.3.4 API CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top API CDMO Services Players by Revenue
3.1.1 Global Top API CDMO Services Players by Revenue (2017-2022)
3.1.2 Global API CDMO Services Revenue Market Share by Players (2017-2022)
3.2 Global API CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by API CDMO Services Revenue
3.4 Global API CDMO Services Market Concentration Ratio
3.4.1 Global API CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by API CDMO Services Revenue in 2021
3.5 API CDMO Services Key Players Head office and Area Served
3.6 Key Players API CDMO Services Product Solution and Service
3.7 Date of Enter into API CDMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 API CDMO Services Breakdown Data by Type
4.1 Global API CDMO Services Historic Market Size by Type (2017-2022)
4.2 Global API CDMO Services Forecasted Market Size by Type (2023-2028)
5 API CDMO Services Breakdown Data by Application
5.1 Global API CDMO Services Historic Market Size by Application (2017-2022)
5.2 Global API CDMO Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America API CDMO Services Market Size (2017-2028)
6.2 North America API CDMO Services Market Size by Country (2017-2022)
6.3 North America API CDMO Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe API CDMO Services Market Size (2017-2028)
7.2 Europe API CDMO Services Market Size by Country (2017-2022)
7.3 Europe API CDMO Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific API CDMO Services Market Size (2017-2028)
8.2 Asia-Pacific API CDMO Services Market Size by Country (2017-2022)
8.3 Asia-Pacific API CDMO Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America API CDMO Services Market Size (2017-2028)
9.2 Latin America API CDMO Services Market Size by Country (2017-2022)
9.3 Latin America API CDMO Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa API CDMO Services Market Size (2017-2028)
10.2 Middle East & Africa API CDMO Services Market Size by Country (2017-2022)
10.3 Middle East & Africa API CDMO Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 EUROAPI
11.1.1 EUROAPI Company Detail
11.1.2 EUROAPI Business Overview
11.1.3 EUROAPI API CDMO Services Introduction
11.1.4 EUROAPI Revenue in API CDMO Services Business (2017-2022)
11.1.5 EUROAPI Recent Development
11.2 Cambrex
11.2.1 Cambrex Company Detail
11.2.2 Cambrex Business Overview
11.2.3 Cambrex API CDMO Services Introduction
11.2.4 Cambrex Revenue in API CDMO Services Business (2017-2022)
11.2.5 Cambrex Recent Development
11.3 Recipharm
11.3.1 Recipharm Company Detail
11.3.2 Recipharm Business Overview
11.3.3 Recipharm API CDMO Services Introduction
11.3.4 Recipharm Revenue in API CDMO Services Business (2017-2022)
11.3.5 Recipharm Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific API CDMO Services Introduction
11.4.4 Thermo Fisher Scientific Revenue in API CDMO Services Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 CordenPharma
11.5.1 CordenPharma Company Detail
11.5.2 CordenPharma Business Overview
11.5.3 CordenPharma API CDMO Services Introduction
11.5.4 CordenPharma Revenue in API CDMO Services Business (2017-2022)
11.5.5 CordenPharma Recent Development
11.6 Samsung Biologics
11.6.1 Samsung Biologics Company Detail
11.6.2 Samsung Biologics Business Overview
11.6.3 Samsung Biologics API CDMO Services Introduction
11.6.4 Samsung Biologics Revenue in API CDMO Services Business (2017-2022)
11.6.5 Samsung Biologics Recent Development
11.7 Lonza
11.7.1 Lonza Company Detail
11.7.2 Lonza Business Overview
11.7.3 Lonza API CDMO Services Introduction
11.7.4 Lonza Revenue in API CDMO Services Business (2017-2022)
11.7.5 Lonza Recent Development
11.8 Catalent
11.8.1 Catalent Company Detail
11.8.2 Catalent Business Overview
11.8.3 Catalent API CDMO Services Introduction
11.8.4 Catalent Revenue in API CDMO Services Business (2017-2022)
11.8.5 Catalent Recent Development
11.9 Siegfried
11.9.1 Siegfried Company Detail
11.9.2 Siegfried Business Overview
11.9.3 Siegfried API CDMO Services Introduction
11.9.4 Siegfried Revenue in API CDMO Services Business (2017-2022)
11.9.5 Siegfried Recent Development
11.10 PiramalPharma Solutions
11.10.1 PiramalPharma Solutions Company Detail
11.10.2 PiramalPharma Solutions Business Overview
11.10.3 PiramalPharma Solutions API CDMO Services Introduction
11.10.4 PiramalPharma Solutions Revenue in API CDMO Services Business (2017-2022)
11.10.5 PiramalPharma Solutions Recent Development
11.11 Boehringer-Ingelheim
11.11.1 Boehringer-Ingelheim Company Detail
11.11.2 Boehringer-Ingelheim Business Overview
11.11.3 Boehringer-Ingelheim API CDMO Services Introduction
11.11.4 Boehringer-Ingelheim Revenue in API CDMO Services Business (2017-2022)
11.11.5 Boehringer-Ingelheim Recent Development
11.12 Wuxi Apptec
11.12.1 Wuxi Apptec Company Detail
11.12.2 Wuxi Apptec Business Overview
11.12.3 Wuxi Apptec API CDMO Services Introduction
11.12.4 Wuxi Apptec Revenue in API CDMO Services Business (2017-2022)
11.12.5 Wuxi Apptec Recent Development
11.13 Pharmaron Beijing
11.13.1 Pharmaron Beijing Company Detail
11.13.2 Pharmaron Beijing Business Overview
11.13.3 Pharmaron Beijing API CDMO Services Introduction
11.13.4 Pharmaron Beijing Revenue in API CDMO Services Business (2017-2022)
11.13.5 Pharmaron Beijing Recent Development
11.14 Asymchem Laboratories (Tianjin)
11.14.1 Asymchem Laboratories (Tianjin) Company Detail
11.14.2 Asymchem Laboratories (Tianjin) Business Overview
11.14.3 Asymchem Laboratories (Tianjin) API CDMO Services Introduction
11.14.4 Asymchem Laboratories (Tianjin) Revenue in API CDMO Services Business (2017-2022)
11.14.5 Asymchem Laboratories (Tianjin) Recent Development
11.15 Porton
11.15.1 Porton Company Detail
11.15.2 Porton Business Overview
11.15.3 Porton API CDMO Services Introduction
11.15.4 Porton Revenue in API CDMO Services Business (2017-2022)
11.15.5 Porton Recent Development
11.16 SEQENS
11.16.1 SEQENS Company Detail
11.16.2 SEQENS Business Overview
11.16.3 SEQENS API CDMO Services Introduction
11.16.4 SEQENS Revenue in API CDMO Services Business (2017-2022)
11.16.5 SEQENS Recent Development
11.17 Lebsa
11.17.1 Lebsa Company Detail
11.17.2 Lebsa Business Overview
11.17.3 Lebsa API CDMO Services Introduction
11.17.4 Lebsa Revenue in API CDMO Services Business (2017-2022)
11.17.5 Lebsa Recent Development
11.18 Langhua Pharma
11.18.1 Langhua Pharma Company Detail
11.18.2 Langhua Pharma Business Overview
11.18.3 Langhua Pharma API CDMO Services Introduction
11.18.4 Langhua Pharma Revenue in API CDMO Services Business (2017-2022)
11.18.5 Langhua Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global API CDMO Services Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Traditional API CDMO
    Table 3. Key Players of Highly Potent API CDMO
    Table 4. Global API CDMO Services Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global API CDMO Services Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global API CDMO Services Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global API CDMO Services Market Share by Region (2017-2022)
    Table 8. Global API CDMO Services Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global API CDMO Services Market Share by Region (2023-2028)
    Table 10. API CDMO Services Market Trends
    Table 11. API CDMO Services Market Drivers
    Table 12. API CDMO Services Market Challenges
    Table 13. API CDMO Services Market Restraints
    Table 14. Global API CDMO Services Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global API CDMO Services Market Share by Players (2017-2022)
    Table 16. Global Top API CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in API CDMO Services as of 2021)
    Table 17. Ranking of Global Top API CDMO Services Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by API CDMO Services Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players API CDMO Services Product Solution and Service
    Table 21. Date of Enter into API CDMO Services Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global API CDMO Services Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global API CDMO Services Revenue Market Share by Type (2017-2022)
    Table 25. Global API CDMO Services Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global API CDMO Services Revenue Market Share by Type (2023-2028)
    Table 27. Global API CDMO Services Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global API CDMO Services Revenue Market Share by Application (2017-2022)
    Table 29. Global API CDMO Services Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global API CDMO Services Revenue Market Share by Application (2023-2028)
    Table 31. North America API CDMO Services Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America API CDMO Services Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe API CDMO Services Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe API CDMO Services Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific API CDMO Services Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific API CDMO Services Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America API CDMO Services Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America API CDMO Services Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa API CDMO Services Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa API CDMO Services Market Size by Country (2023-2028) & (US$ Million)
    Table 41. EUROAPI Company Detail
    Table 42. EUROAPI Business Overview
    Table 43. EUROAPI API CDMO Services Product
    Table 44. EUROAPI Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 45. EUROAPI Recent Development
    Table 46. Cambrex Company Detail
    Table 47. Cambrex Business Overview
    Table 48. Cambrex API CDMO Services Product
    Table 49. Cambrex Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 50. Cambrex Recent Development
    Table 51. Recipharm Company Detail
    Table 52. Recipharm Business Overview
    Table 53. Recipharm API CDMO Services Product
    Table 54. Recipharm Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 55. Recipharm Recent Development
    Table 56. Thermo Fisher Scientific Company Detail
    Table 57. Thermo Fisher Scientific Business Overview
    Table 58. Thermo Fisher Scientific API CDMO Services Product
    Table 59. Thermo Fisher Scientific Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 60. Thermo Fisher Scientific Recent Development
    Table 61. CordenPharma Company Detail
    Table 62. CordenPharma Business Overview
    Table 63. CordenPharma API CDMO Services Product
    Table 64. CordenPharma Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 65. CordenPharma Recent Development
    Table 66. Samsung Biologics Company Detail
    Table 67. Samsung Biologics Business Overview
    Table 68. Samsung Biologics API CDMO Services Product
    Table 69. Samsung Biologics Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 70. Samsung Biologics Recent Development
    Table 71. Lonza Company Detail
    Table 72. Lonza Business Overview
    Table 73. Lonza API CDMO Services Product
    Table 74. Lonza Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 75. Lonza Recent Development
    Table 76. Catalent Company Detail
    Table 77. Catalent Business Overview
    Table 78. Catalent API CDMO Services Product
    Table 79. Catalent Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 80. Catalent Recent Development
    Table 81. Siegfried Company Detail
    Table 82. Siegfried Business Overview
    Table 83. Siegfried API CDMO Services Product
    Table 84. Siegfried Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 85. Siegfried Recent Development
    Table 86. PiramalPharma Solutions Company Detail
    Table 87. PiramalPharma Solutions Business Overview
    Table 88. PiramalPharma Solutions API CDMO Services Product
    Table 89. PiramalPharma Solutions Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 90. PiramalPharma Solutions Recent Development
    Table 91. Boehringer-Ingelheim Company Detail
    Table 92. Boehringer-Ingelheim Business Overview
    Table 93. Boehringer-Ingelheim API CDMO ServicesProduct
    Table 94. Boehringer-Ingelheim Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 95. Boehringer-Ingelheim Recent Development
    Table 96. Wuxi Apptec Company Detail
    Table 97. Wuxi Apptec Business Overview
    Table 98. Wuxi Apptec API CDMO ServicesProduct
    Table 99. Wuxi Apptec Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 100. Wuxi Apptec Recent Development
    Table 101. Pharmaron Beijing Company Detail
    Table 102. Pharmaron Beijing Business Overview
    Table 103. Pharmaron Beijing API CDMO ServicesProduct
    Table 104. Pharmaron Beijing Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 105. Pharmaron Beijing Recent Development
    Table 106. Asymchem Laboratories (Tianjin) Company Detail
    Table 107. Asymchem Laboratories (Tianjin) Business Overview
    Table 108. Asymchem Laboratories (Tianjin) API CDMO ServicesProduct
    Table 109. Asymchem Laboratories (Tianjin) Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 110. Asymchem Laboratories (Tianjin) Recent Development
    Table 111. Porton Company Detail
    Table 112. Porton Business Overview
    Table 113. Porton API CDMO ServicesProduct
    Table 114. Porton Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 115. Porton Recent Development
    Table 116. SEQENS Company Detail
    Table 117. SEQENS Business Overview
    Table 118. SEQENS API CDMO ServicesProduct
    Table 119. SEQENS Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 120. SEQENS Recent Development
    Table 121. Lebsa Company Detail
    Table 122. Lebsa Business Overview
    Table 123. Lebsa API CDMO ServicesProduct
    Table 124. Lebsa Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 125. Lebsa Recent Development
    Table 126. Langhua Pharma Company Detail
    Table 127. Langhua Pharma Business Overview
    Table 128. Langhua Pharma API CDMO ServicesProduct
    Table 129. Langhua Pharma Revenue in API CDMO Services Business (2017-2022) & (US$ Million)
    Table 130. Langhua Pharma Recent Development
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global API CDMO Services Market Share by Type: 2021 VS 2028
    Figure 2. Traditional API CDMO Features
    Figure 3. Highly Potent API CDMO Features
    Figure 4. Global API CDMO Services Market Share by Application in 2021 & 2028
    Figure 5. Pharmaceutical Company Case Studies
    Figure 6. Research Institute Case Studies
    Figure 7. API CDMO Services Report Years Considered
    Figure 8. Global API CDMO Services Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global API CDMO Services Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global API CDMO Services Market Share by Region: 2021 VS 2028
    Figure 11. Global API CDMO Services Market Share by Players in 2021
    Figure 12. Global Top API CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in API CDMO Services as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by API CDMO Services Revenue in 2021
    Figure 14. North America API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 15. North America API CDMO Services Market Share by Country (2017-2028)
    Figure 16. United States API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. Canada API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Europe API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe API CDMO Services Market Share by Country (2017-2028)
    Figure 20. Germany API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. France API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. U.K. API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Italy API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Russia API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Nordic Countries API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific API CDMO Services Market Share by Region (2017-2028)
    Figure 28. China API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Japan API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. South Korea API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Southeast Asia API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. India API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Australia API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Latin America API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America API CDMO Services Market Share by Country (2017-2028)
    Figure 36. Mexico API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Brazil API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Middle East & Africa API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa API CDMO Services Market Share by Country (2017-2028)
    Figure 40. Turkey API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Saudi Arabia API CDMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. EUROAPI Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 43. Cambrex Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 44. Recipharm Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 45. Thermo Fisher Scientific Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 46. CordenPharma Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 47. Samsung Biologics Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 48. Lonza Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 49. Catalent Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 50. Siegfried Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 51. PiramalPharma Solutions Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 52. Boehringer-Ingelheim Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 53. Wuxi Apptec Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 54. Pharmaron Beijing Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 55. Asymchem Laboratories (Tianjin) Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 56. Porton Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 57. SEQENS Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 58. Lebsa Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 59. Langhua Pharma Revenue Growth Rate in API CDMO Services Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Medical Simulation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-7S2681
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Patient-derived Xenograft (PDX) Models Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22N5886
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Defensin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24X10377
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Acupuncture Needles Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-27A351
Wed Mar 19 00:00:00 UTC 2025

Add to Cart